ABA Home
 
U.S. Supreme Court

Scalia Deems Medical Device Liability ‘Extraordinary’

Posted Dec 5, 2007, 06:48 am CST
By Debra Cassens Weiss

Updated: Several justices wondered in U.S. Supreme Court oral arguments yesterday whether juries in product liability cases should be allowed to consider the safety of a medical device that has been approved by the government.

At issue in Riegel v. Medtronic is whether the tort claim is pre-empted by the Medical Device Amendments to the Food, Drug and Cosmetic Act, Law.com reports. The plaintiffs in the case, Charles Riegel and his wife, sued over a Medtronic balloon catheter that burst during Riegel’s angioplasty.

The Food and Drug Administration had given “premarket approval” to the catheter. The Bush administration argued in favor of pre-emption, the New York Times reports.

Antonin Scalia was among the justices who expressed concern about allowing juries to consider the safety of FDA-approved devices. "What's going on is simply one jury has decided that in its judgment, there was a safer device that should have been used; and because of the judgment of that one jury, the manufacturer is placed at risk in selling a device that scientists at the FDA have said is OK. I find that extraordinary," he said.

The Drug and Device Law blog says it is "cautiously optimistic" that the court will rule the product liability suit is pre-empted by federal law.

Updated at 1:30 PM to include Drug and Device Law blog prediction.



Add Comment

We welcome your comments, but please adhere to our comment policy.


Most Read



Subscribe

Get the ABA Journal the way you want it — in print, online, by e-mail — and when you want it — monthly, weekly, daily or as news breaks.



Subscribe via RSS
Subscribe to the mobile edition
Subscribe to the monthly magazine


Return to top